![](data:image/svg+xml;charset=utf-8,<svg height="32" width="135" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
₹ 418.00
Open
421.55High
422.35Low
406.8Prev Close
422.35P/E
25.89Median P/E
31.46P/B
3.61Median P/B
4.53Market Cap
101.31BPEG
0.49Div.Yield
0.36Bid
408.30Ask
-Large Cap
101.31B Mkt. Cap.Volatility
-Beta
0.55Genie Says
Influencer Count
-| Days | BSE | NSE |
|---|
| 5 | 421.82 | 421.98 |
| 10 | 417.48 | 417.54 |
| 20 | 427.52 | 427.64 |
| 50 | 437.66 | 437.75 |
| 100 | 422.25 | 422.34 |
| 300 | 377.51 | 377.58 |
BSE
532482NSE
GRANULESISIN
INE101D01020Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
Krishna Chigurupati
Executive Chairman of the Board, Managing DirectorKandiraju Rao
Chief Executive Officer, Joint Managing Director, Executive DirectorMukesh Surana
Chief Financial OfficerAnil Arora
Corporate ExecutiveAtul Dhavle
Chief Human Resource OfficerSanjay Kumar
Senior Vice President - Corporate Strategy & PlanningG. N. Prashanth
Senior Vice President & Head Corporate QualityManikandan Ramalingam
Senior Vice President & Head Formulation R&DSethu Sankaran
Senior Vice President - API Manufacturing & OperationsChaitanya Tummala
Compliance Officer, Company Secretary